Intervention

Radiation therapy

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 59 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials59

Recruiting3

Common conditions25

Lead sponsors shown15

Clinical trials

59 shown

Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate CancerNCT07364071 · 2026-07-20

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNCT04075305 · 2019-02-01

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerNCT02468024 · 2015-07-01

Radiation Therapy (RT) for Parkinson's Disease (PD)NCT07218952 · 2026-01-20

ENROLLING_BY_INVITATION

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLCNCT06177925 · 2023-12-10

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsNCT05704985 · 2023-04-03

ACTIVE_NOT_RECRUITING

Prostate Cancer IRE Study (PRIS)NCT05513443 · 2022-09-01

ACTIVE_NOT_RECRUITING

RElugolix VErsus LeUprolide Cardiac TrialNCT05320406 · 2022-06-06

ACTIVE_NOT_RECRUITING

Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast CancerNCT04837209 · 2021-07-21

ACTIVE_NOT_RECRUITING

A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung CancerNCT04905316 · 2021-05-21

SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLCNCT04562337 · 2020-10-01

A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving RadiotherapyNCT04381988 · 2020-05-07

SIGNAL During a COVID-19 PandemicNCT05037019 · 2020-05-01

Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung CancerNCT03916419 · 2019-06-20

Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapyNCT03824366 · 2019-04-23

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)NCT03725059 · 2018-12-27

ACTIVE_NOT_RECRUITING

Chemoradiation vs Immunotherapy and Radiation for Head and Neck CancerNCT03383094 · 2018-03-15

ACTIVE_NOT_RECRUITING

Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)NCT03168464 · 2017-10-09

Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)NCT03109080 · 2017-07-24

Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast CancerNCT03213925 · 2017-06-01

Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC)NCT02934503 · 2017-01-23

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving SurgeryNCT03320421 · 2017-01-01

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790MNCT02972333 · 2016-12-01

Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate CancerNCT02911922 · 2016-09-01

Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer PatientsNCT02528942 · 2016-04-22

Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and RadiotherapyNCT02679040 · 2016-01-27

LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast CancerNCT02538471 · 2015-08-10

Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) PatientsNCT02499367 · 2015-08-01

Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer PatientsNCT02376413 · 2015-03-01

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the HeartNCT02052102 · 2014-10-01

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate CancerNCT02023463 · 2014-04-02

ACTIVE_NOT_RECRUITING

Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive ChemoradiationNCT01836341 · 2013-04-01

Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation TherapyNCT01819233 · 2013-03-08

FACBC Outcomes for Post ProstatectomyNCT01666808 · 2012-09-01

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerNCT01546987 · 2012-05-01

Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer PatientsNCT01503905 · 2011-12-01

Tecemotide (L-BLP25) in Prostate CancerNCT01496131 · 2011-10-24

Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast CancerNCT01167192 · 2011-02-01

Cytokine Expression During Radiation for Breast CancerNCT00836186 · 2009-11-13

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer PatientsNCT01546376 · 2009-08-01

Temsirolimus and Radiation for Non-Small Cell Lung CancerNCT00796796 · 2009-03-01

Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate CancerNCT03432780 · 2008-12-18

Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLCNCT00544648 · 2007-11-01

Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate CancerNCT00348816 · 2006-05-01

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung CancerNCT00080938 · 2005-12-20

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate CancerNCT00288080 · 2005-12-01

Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung CancerNCT00301808 · 2005-11-01

Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic ResponseNCT02280252 · 2005-03-01

Radiation Therapy in Treating Women With Localized Breast CancerNCT00107497 · 2004-10-05

Phase II Iressa + Irradiation Followed by Chemo in NSCLCNCT00333294 · 2004-09-01

Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast CancerNCT00084539 · 2003-11-01

Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerNCT00066222 · 2003-06-01

Phase II Study for Solid Metastatic TumorsNCT02474186 · 2003-04-01

Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLCNCT00238615 · 2003-03-01

Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung CancerNCT00048997 · 2002-09-01

Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate CancerNCT00040365 · 2002-06-01

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate CancerNCT00004054 · 2000-01-01

High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple SclerosisNCT00040482 · 1999-04-01

Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung CancerNCT01134861 · 1994-07-01

Common conditions

Leading sponsors

Radiation Therapy Oncology Group6 Washington University School of Medicine4 Memorial Sloan Kettering Cancer Center3 NYU Langone Health3 Weill Medical College of Cornell University3 Emory University2 Shandong Cancer Hospital and Institute2 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2 AHS Cancer Control Alberta1 AstraZeneca1 Barbara Ann Karmanos Cancer Institute1 Baylor College of Medicine1 Chinese Academy of Medical Sciences1 DEKA Biosciences1 Department of Medical Services Ministry of Public Health of Thailand1

Trial status mix

COMPLETED26

UNKNOWN10

TERMINATED9

ACTIVE_NOT_RECRUITING7

RECRUITING3

WITHDRAWN3

ENROLLING_BY_INVITATION1

Phase mix

PHASE232

NA11

PHASE39

PHASE17

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.